Yahoo Search Busca da Web

Resultado da Busca

  1. Há 4 dias · Metastatic colorectal cancer ... The portal vein, which drains blood from the gastrointestinal tract, ... the spread of cancer to regional lymph nodes is associated with diminished DFS 15.

  2. 8 de mai. de 2024 · Abnormal angiogenesis leads to tumor progression and metastasis in colorectal cancer (CRC). This study aimed to elucidate the association between angiogenesis-related genes, including...

  3. Há 4 dias · Data collected from inpatient and outpatient records included: demographic data (age and sex); preoperative factors (neoadjuvant therapy, preoperative complication); tumor-specific details (histology, location, T classification, venous and lymphatic duct invasion, lymph node metastasis, distant metastasis); survival data (DFS and OS); and surgical details (surgical approach, operation time ...

  4. Há 2 dias · TCF7L2 can promote gastric cancer metastasis by regulating PLAUR and forming a MIR100HG/hnRNPA2B1/TCF7L2 axis to promote CRC metastasis . BACH1 is able to activate the transcription of Hexokinase 2 and GAPDH and thereby promotes lung cancer metastasis . These results could suggest new targets for CRC metastasis prevention and prognosis.

  5. 22 de mai. de 2024 · Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death worldwide [].In recent years, with the widespread use of cancer screening programs, the introduction of molecularly targeted biological drugs, and the use of surgical and local ablative treatments in metastatic patients, mortality has decreased and survival outcomes have improved [].

  6. 6 de mai. de 2024 · Colorectal cancer (CRC) is prone to metastasis and recurrence after surgery, which is one of the main causes for its poor treatment and prognosis. Therefore, it is essential to identify biomarkers associated with metastasis and recurrence in CRC.

  7. 4 de mai. de 2024 · The treatment of metastatic colorectal cancer (mCRC) remains challenging. There has been substantial progress in understanding the molecular pathology of the disease that has led to meaningful advancements in treatment options with varying mechanisms of action, although treatment remains costly.